Quick Answer
Protein Intake Satiety Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Cow's milk compared to oat drink and its implications for lipid profile- a pilot randomized controlled trial.
Key Takeaways
- 01Cow's milk compared to oat drink and its implications for lipid profile- a pilot randomized controlled trial. [Rosendahl-Riise H (2026)]
- 02A high-carb/high-fat diet increases plasma concentrations of lipopolysaccharides (LPS), tumor necrosis factor alpha (TNF-α), interleukins 1 beta (IL1-β), and IL-6, causing a chronic hyperphagia [,,], insulin resistance, type 2 diabetes, and associated comorbidities []. [de França Elias (2026)]
- 03L-leucine supplementation has been shown to be effective in inducing increased plasma levels of anorectic peptides [,], with an anorexic effect in animal models by inducing activation in neuron pathways in regions of the central nervous system that are responsible for appetite inhibition [,]. [de França Elias (2026)]
- 0414 15 16 17 15 16 12 18 1 Beyond an insulin mimicker [], evidence in animal models suggests that the restoration or maintenance of satiety mechanisms may occur with physical exercise practice, since acute physical exercise induces an increase in anorectic neuropeptides such as GLP-1 and CCK while decreasing ghrelin [,]. [de França Elias (2026)]
The current Migaku evidence database contains 2 reusable source documents for Protein Intake Satiety Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- Cow's milk compared to oat drink and its implications for lipid profile- a pilot randomized controlled trial. [Rosendahl-Riise H (2026); evidence level 2]
- A high-carb/high-fat diet increases plasma concentrations of lipopolysaccharides (LPS), tumor necrosis factor alpha (TNF-α), interleukins 1 beta (IL1-β), and IL-6, causing a chronic hyperphagia [,,], insulin resistance, type 2 diabetes, and associated comorbidities []. [de França Elias (2026); evidence level 2]
- L-leucine supplementation has been shown to be effective in inducing increased plasma levels of anorectic peptides [,], with an anorexic effect in animal models by inducing activation in neuron pathways in regions of the central nervous system that are responsible for appetite inhibition [,]. [de França Elias (2026); evidence level 2]
- 14 15 16 17 15 16 12 18 1 Beyond an insulin mimicker [], evidence in animal models suggests that the restoration or maintenance of satiety mechanisms may occur with physical exercise practice, since acute physical exercise induces an increase in anorectic neuropeptides such as GLP-1 and CCK while decreasing ghrelin [,]. [de França Elias (2026); evidence level 2]
- 1 2 3 4 4 5 6 7 8 9 10 10 11 The dysregulation in the satiety mechanism in the hypothalamus in obese animal models is triggered by a chronic systemic low-grade inflammatory process induced by a high-carb/high-fat diet. [de França Elias (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources